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Abstract
Objective: This study aims to undertake the first critical review of self-care use among adults with sleep
disturbances by focusing on the prevalence of self-care—the self-determined and self-administered use of products
or practices—by adults with sleep disturbances.
Methods: A comprehensive search of 2006–2016 international literature in CINAHL, AMED, Medline and EMBASE
databases was conducted. The search was confined to empirical research findings regarding sleep disturbances - as
indicated by a validated sleep scale/index or clinician diagnosis.
Results: Of the 21 articles included in this review, only three reported on sleep disturbances other than insomnia
disorder (ID) or insomnia symptoms (IS). Overall, a high prevalence of self-care use is reported among adults with
sleep disturbances, particularly for ID and IS. Self-care products and practices are more likely to be used by adults
with sleep disturbances, than those without sleep disturbances. Commonly used self-care products and practices
include OTC hypnotics, antihistamines, diphenhydramine products, diet, exercise, painkillers, herbal medicines,
vitamins, minerals and dietary supplements, yoga, tai chi, Qigong, meditation, exercise and relaxation.
Conclusions: Many adults with sleep disturbances–particularly ID or IS–frequently use self-care products and practices.
Self-care products are also used concomitantly with conventional prescription medications without disclosure to
medical professionals. The current literature is of varied methodological caliber, frequently relies on small sample sizes
and low-quality data collection therefore further rigorous health services research is required. There is an especial
paucity of data regarding self-care for sleep disturbances such as restless legs syndrome and obstructive sleep apnea.
Healthcare providers may find it beneficial to actively ask patients about their use of self-care for sleep disturbances to
help avoid harmful drug-drug or drug-herb interactions.
Keywords: Restless legs syndrome, Self care, Sleep apnea syndromes, Sleep initiation and maintenance disorders,
Complementary therapies, Patient-centered care, Critical review
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Introduction
Sleep disturbances such as insomnia symptoms (IS)—char-
acterized by difficulty in initiating or maintaining sleep
(Morin et al. 2006; Ohayon 2001)—can affect up to a third
of the population internationally (Léger et al. 2007; Ohayon
2002) and up to 56% in the USA (Léger et al. 2007). Older
people and women are particularly susceptible, the intersec-
tion of these characteristics causing prevalence estimates of
IS to rise to between 49 and 72% (Byles et al. 2005; Mere-
dith et al. 2017; Meredith et al. 2019) within nationally rep-
resentative cohorts of older women in Australia. Distinct
from IS, insomnia disorder (ID), as well as including diffi-
culties initiating or maintaining sleep, is also characterized
by dissatisfaction with sleep quality or duration and with
significant distress and impairments of daytime functioning
(Morin et al. 2015). Compared with IS alone, ID is known
to affect a significant but reduced proportion of the popula-
tion of between 3.9–22.1% (Morin et al. 2015). Other com-
mon sleep disturbances such as restless legs syndrome
(RLS) and sleep disordered breathing (SDB) have been re-
ported to affect up to 29% (Innes et al. 2011) and 38%
(Senaratna et al. 2017) of the population respectively and
represent a major public health issue. SDB and RLS also
affect older populations disproportionately (Innes et al.
2011; Senaratna et al. 2017; Leger et al. 2012).
Varying definitions of self-care are rapidly emerging, in
tandem with a trend toward patient-centered health care
and an increase in chronic over acute, conditions (Mun
et al. 2016). Here, we define self-care as the self-determined
and self-administered use of products or practices for ad-
dressing health problems and/or maintaining health prac-
ticed by individuals without instruction from healthcare
professionals in line with established research definitions
(Mun et al. 2016; Adams et al. 2018). Both complementary
and alternative medicine (CAM) self-care (e.g. taking herbs
or practicing meditation) and conventional self-care (e.g.
exercise or over-the-counter (OTC) drugs such as acet-
aminophen) have become increasingly popular in Western
societies (Frass et al. 2012; Qato et al. 2008).
Frontline conventional medical treatments for sleep
disturbances are typically prescription medications
including benzodiazepines, zolpidem and zopiclone
for insomnia, and dopaminergic agents for restless
legs syndrome (RLS), all of which can have harmful
side effects (Wang et al. 2014; Leach and Page 2015;
Gamaldo and Earley 2006). Frontline solutions for
other sleep disturbances such as obstructive sleep
apnea (OSA), which include continuous positive air-
way pressure (CPAP) machines and surgery, have
also presented problems including accessibility, ad-
herence, disruption of bed-partners’ sleep (Knauert
et al. 2015; Weaver et al. 2003), high morbidity, and
ambivalent results in the case of surgical treatment
(Knauert et al. 2015).
There is evidence to suggest many people with sleep
disturbances avoid seeking professional medical help
partly due to aforementioned concerns, and as a way for
people to maintain a feeling of control over their health
(Knauert et al. 2015; Venn et al. 2013). Adults with sleep
disturbances sometimes consider self-care products
(such as natural herbs or OTC pharmaceuticals such as
Diphenhydramine or Doxylamine) effective alternatives
to seeking professional medical help (Meredith et al.
2017; Abraham et al. 2017) as well as self-care practices
including relaxation techniques, yoga and tai chi (Ber-
tisch et al. 2009).
Popular self-care products and practices for sleep dis-
turbances include, drinking chamomile tea or a hot milk
before sleep, taking OTC medications such as antihista-
mines, herbal medicines, Chinese medicines, melatonin
(as reported in countries in which it is considered an
OTC), engaging in meditation and relaxation techniques
(Meredith et al. 2017; Bertisch et al. 2009; Boon et al.
2013; Cherniack et al. 2008; Fouladbakhsh and Stommel
2010; Frawley et al. 2015; Furihata et al. 2011; Liu et al.
2016; Moore et al. 2011; Pearson et al. 2006; Tsai et al.
2008; Williams et al. 2014).
Although in some cases these options are promoted as
safer options compared to prescription treatments for
certain sleep disturbances, with reduced or no side ef-
fects (Fernández-San-Martín et al. 2010), there is limited
evidence of efficacy and safety, with specific concern
about OTC products taken without medical advice
(Meredith et al. 2017; Abraham et al. 2017) particularly
in the context of undisclosed concurrent use with med-
ical drugs (Leach and Page 2015). Nonetheless, research
suggests that self-care products and practices are utilized
more frequently than prescription medications by people
with sleep disturbances (Morin et al. 2006; Sivertsen
et al. 2009; Sánchez-Ortuño et al. 2009; Worthington
and Melia 2006).
Due to the high use of self-care products for sleep dis-
turbances, confusion over best treatments for individual
sleep disturbances, absence of information regarding
adults’ treatment preferences and safety concerns about
overuse and concurrent use with pharmaceutical medi-
cations, a synthesis of this information is timely.
Empirical research indicating the prevalence of use of
health services—including self-care for the treatment of
sleep disturbances—has become increasingly available
over the last 10 years (Meredith et al. 2017; Sandberg
et al. 2014). Whilst there is a significant body of research
focusing exclusively on the heightened use of conven-
tional medical services for people with sleep distur-
bances (Blay et al. 2008; Moloney et al. 2011; Novak
et al. 2004; Sarsour et al. 2011; Kaufmann et al. 2013;
Bin et al. 2012), prevalence information on the use of
self-care, including OTC medicine use is scattered with
Meredith et al. Sleep Science and Practice             (2020) 4:4 Page 2 of 17
articles focusing mostly on just one or two aspects of
use (e.g. herbs or OTC medications). A critical synthesis
of health strategies in the management of sleep distur-
bances has not been undertaken to date. In response to
this gap, this paper reports findings from the first review
of self-care use among individuals with sleep distur-
bances. As well as helping identify patterns of use of
self-care products (such as OTCs) it will also investigate
concurrent use of self-care products with prescription
medicine which, without medical advice, may be associ-
ated with safety issues (Leach and Page 2015).
This review, in also seeking to explore self-care prac-
tices generally considered safe (such as yoga and relax-
ation techniques) also aims to identify both potentially
risky and effective self-care options for various sleep dis-
turbances that may currently be being initiated beyond
the purview of medical practitioners. As what is consid-
ered ‘risky’ may depend upon the sleep disturbance itself,




CINAHL, AMED, the Medline and EMBASE databases
were searched for articles published from 2006 to 2016
that used key words and phrases relating to sleep distur-
bances AND key words and phrases related to self-care
options. The CINAHL, Medline and EMBASE are three
of the most wide-ranging and utilized databases in med-
ical and health scholarship. We supplemented this
search with use of the AMED database, known as an au-
thoritative resource for scholarship in complementary
and alternative medicine. The search was limited to
peer-reviewed articles published in the English language
between 2006 and 2016.
Self-care was defined—in line with established re-
search definitions (Mun et al. 2016; Adams et al.
2018)—as the self-determined and self-administered use
of products or practices for addressing health problems
and/or maintaining health practiced by individuals with-
out instruction from healthcare professionals. Details of
the search criteria can be found in the Additional file 1.
Sleep disturbances represent a broad spectrum of
complaints with different treatment options available.
Diagnostic criteria and definitions for individual sleep
disturbances and their symptoms are varied and numer-
ous. Consistent nosology with sufficient clarity of defin-
ition, has thus far remained elusive (Morin and Espie
2011). Research also suggests that the absence of clear
scales and diagnostic instruments for the identification
of sleep disturbances can cause a heterogeneity of results
that are sometimes difficult to rely upon (Ohayon et al.
2012; Henry et al. 2016). Consequently, to enable mean-
ingful comparison and collation of results, we only
included articles where a validated sleep scale or index
was used, or where the condition was diagnosed by a
clinician.
Studies were considered to be assessing ID if they used
a validated tool/measure widely used for the validation of
insomnia such as the Insomnia Severity Index (ISI), the
APA Diagnostic and Statistical Manual of Mental Disor-
ders (DSM-IV), the Brief Insomnia Questionnaire (BIQ)
and the International Classification of Sleep Disorders
(ICSD) or a physician diagnosis. Articles were also in-
cluded with reported IS if the article indicated that partici-
pants had symptoms of insomnia—such as frequent
nocturnal awakenings, the presence of a long sleep latency
or extended periods of wakefulness during the period of
sleep (Sateia et al. 2000) as indicated by a validated sleep
scale used to measure IS such as the medical outcomes
study sleep scale (MOS-SS) and the Pittsburgh sleep qual-
ity index (PSQI). Further, in this review, the category ‘ID
and IS’ include some articles which report ‘poor sleep’ and
sleep-wake disturbance (SWD) because the Pittsburgh
Sleep Quality Index (PSQI) (used for studies reporting
poor sleep) and the Insomnia Severity Index (ISI) (used
for the study reporting on SWD) have been validated as
measures for ID and IS (Backhaus et al. 2002; Bastien
et al. 2001) therefore people with poor sleep and SWD as
defined using these tools will likely be seeking treatments
for symptoms related to insomnia. Similarly, other sleep
disturbances were included in the review if they employed
rigorous tools for screening such as physician diagnosis,
widely accepted diagnostic criteria and validated indexes
such as the apnea-hypopnea index (AHI) and the respira-
tory disturbance index (RDI). As there is currently no syn-
thesis of self-care literature for any type of sleep
disturbance or disorder. This review of the international
literature is thus intended as a starting point and a plat-
form for further research concerning self-care treatments
for disturbed sleep by adults.
For a detailed overview of the search design and cri-
teria see Additional file 1.
Search outcomes
The initial search identified 7990 articles after duplicates
were removed. Of these, 21 articles from 19 empirical
studies (two projects were reported by more than one
article) met inclusion criteria and were included in the
review. A summary of findings from included papers is
reported in Table 1:
Quality appraisal
A quality scoring system was utilized in order to assess
the quality of the final papers selected for review
(Table 2). The scoring system employed an established
analytical tool used in numerous health reviews (Bishop
et al. 2011; Fejer et al. 2006; Peng et al. 2014; Moore
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Table 1 Research-based studies of self-care for adults for sleep disturbances, 2006–2016
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Table 1 Research-based studies of self-care for adults for sleep disturbances, 2006–2016 (Continued)
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Table 1 Research-based studies of self-care for adults for sleep disturbances, 2006–2016 (Continued)
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et al. 2017; Adams et al. 2013)—enabled methodical
evaluation and comparison of the self-care for sleep
studies reviewed:
Scores were assigned to the studies separately by
two authors; variances in results were resolved
through discussion by all authors. Quality scores of
individual studies are presented in Table 3.
Results
A critical review method (Peng et al. 2014; Moore et al.
2017) was used to excerpt, group and review the key
findings of the 21 articles. Extracted data were synthe-
sized into three main themes: prevalence of self-care by
adults with sleep disturbances; profile, predictors and
motivation for the use of self-care by adults with sleep
Table 1 Research-based studies of self-care for adults for sleep disturbances, 2006–2016 (Continued)
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disturbances and Information-seeking, communication
with medical providers and self-reported effectiveness of
self-care by adults for sleep disturbances.
A vast majority of the articles included in this review
focused on adults with ID or IS (Morin et al. 2006; Venn
et al. 2013; Liu et al. 2016; Sánchez-Ortuño et al. 2009;
Bin et al. 2012; Homsey and O’Connell 2012; Allen et al.
2008; Andrews et al. 2013; Braley et al. 2015; Cheung
et al. 2014; Daley et al. 2009; Henry et al. 2013; Krakow
et al. 2014; Matthews et al. 2016; Rosenthal et al. 2008;
Table 2 Description of quality scoring system for the self-care surveys reviewed
Dimensions of quality assessment Points awardeda
Methodology
1. Representative Sampling Strategy 1
2. Sample size > 500 1
3. Response rate > 75% 1
4. Low recall bias (prospective data collection or retrospective data collection within the past 12 months) 1
Reporting of participants characteristics
5. Classification of specific sleep disturbance reported (e.g. insomnia/sleep apnea). 1
6. Age 1
7. Ethnicity 1
8. Indicator of socioeconomic status (income, education) 1
9. Gender 1
Reporting of self-care
10. Definition of self-care products or practices provided to participants 1
11. Participants can name self-care products/practices used (open question). 1
12. Use of self-care products or practices assessed 1
aThe maximal score is 12 points
Table 3 Quality scores of studies on self-care for sleep disturbances
Dimensions of quality assessment
Authors/year Methodology Reporting of participant characteristics Reporting of self-care Total score
Allen et al. 2008 2 (2,4) 3 (6,7,9) 2 (10,12) 7
Andrews et al. 2013 1 (4) 1 (5) 1 (11) 3
Bin et al. 2012 (1) 3 (1,2,4) 4 (5,6,8,9) 2 (10,12) 9
Braley et al. 2015 1 (3) 1(5) 0 2
Daley et al. 2009 2 (2,4) 1 (5) 3 (10,11,12) 6
Henry et al. 2013 0 1 (5) 1 (11) 1
Homsey and O’Connell 2012 0 3 (6,8,9) 2 (10,12) 5
Krakow et al. 2014 3 (2,3,4) 5 (5,6,7,8,9) 0 8
Liu et al. 2016 1 (2) 4 (5,6,8,9) 0 5
Morin et al. 2006 3 (2,4) 4 (5,6,8,9) 3 (10,11,12) 10
Petrov et al. 2014 1 (4) 5 (5, 6, 7, 8, 9) 0 6
Rosenthal et al. 2008 0 0 0 0
Sánchez-Ortuño et al. 2009 2 (2,4) 4 (5,6,8,9) 3 (10,11,12) 10
Suen et al. 2008 0 0 2 (10,12) 2
Vallieries et al. 2014 1 (4) 4 (5,6,8,9) 0 6
Wahner-Roedler et al. 2007 2 (3,4) 2 (5,9) 3 (10,11,12) 7
Yeung et al. 2014 1 (4) 4 (5,6,8,9) 2 (10,12) 7
Cheung et al. (2014) (17), Matthews et al. (2016) (73), Venn and Arber (2012), (18) and Venn et al. (2013), (14) were solely qualitative studies and were not
assessed via the quality scoring system
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Suen et al. 2008; Vallieres et al. 2014; Venn and Arber
2012; Yeung et al. 2014). Appropriate self-care for ID or
IS may be decidedly different for someone with certain
symptoms related to, for example, SDB and thus, the
few articles that discuss sleep disturbances other than ID
or IS—that is those related to SDB (Braley et al. 2015;
Petrov et al. 2014; Wahner-Roedler et al. 2007) and RLS
(Braley et al. 2015)—are discussed separately in this re-
view. One article that examines the OTC use of different
patient groups with either insomnia, RLS or OSA (Braley
et al. 2015) will be discussed in both the ‘ID or IS’, and




The quality scoring system revealed a breadth of data
quality. Four papers were not able to be included in the
assessment due to being qualitative papers (Venn et al.
2013; Cheung et al. 2014; Matthews et al. 2016; Venn
and Arber 2012), a further four scored two points or
under (Braley et al. 2015; Henry et al. 2013; Rosenthal
et al. 2008; Suen et al. 2008) demonstrating low meth-
odological quality, and only one paper (Bin et al. 2012)
investigating ID or IS employed a representative sam-
pling strategy thus limiting the generalizability of these
results. However, more than half of the 19 papers in-
cluded in the review scored over five points (Morin et al.
2006; Liu et al. 2016; Sánchez-Ortuño et al. 2009; Bin
et al. 2012; Homsey and O’Connell 2012.; Allen et al.
2008; Daley et al. 2009; Krakow et al. 2014; Vallieres
et al. 2014; Yeung et al. 2014) implying a reasonable
level of methodological strength and usefulness across
the listed criteria and a third of the papers included used
sample sizes of over 500 (Morin et al. 2006; Liu et al.
2016; Sánchez-Ortuño et al. 2009; Bin et al. 2012; Allen
et al. 2008; Daley et al. 2009; Krakow et al., 2014) mak-
ing it possible to determine some useful patterns and
themes.
Other sleep disturbances (SDB and RLS)
Just three papers—all of which investigated use of self-
care for SDB (Braley et al. 2015; Petrov et al. 2014;
Wahner-Roedler et al. 2007) and one of which also in-
vestigated use of self-care for insomnia (see above) and
RLS (Braley et al. 2015)—explored the use of self-care
for sleep disturbances other than ID or IS thus making
generalizations difficult. However, two of these studies
scored over 5 points in the quality scoring system (Pet-
rov et al. 2014; Wahner-Roedler et al. 2007) and one had
a large sample size of > 500 (Petrov et al. 2014) helping
to provide a starting point for further research into self-
care for SDB, while a knowledge-base with regards to
RLS and self-care needs to be developed.
Prevalence of self-care by adults with ID or IS
19 out of 21 articles in this review included a focus on
ID or IS (Morin et al. 2006; Venn et al. 2013; Liu et al.
2016; Sánchez-Ortuño et al. 2009; Bin et al. 2012; Hom-
sey and O’Connell 2012.; Allen et al. 2008; Andrews
et al. 2013; Braley et al. 2015; Cheung et al. 2014; Daley
et al. 2009; Henry et al. 2013; Krakow et al. 2014; Mat-
thews et al. 2016; Rosenthal et al. 2008; Suen et al. 2008;
Vallieres et al. 2014; Venn and Arber 2012; Yeung et al.
2014). While these articles report wide-ranging self-care
prevalence rates for sleep disturbances, it is clear from
the literature that self-care for ID or IS is common.
OTC use reported by four large studies including n >
500 participants with ID or IS was between 12 and 76%
(mean 35%, median 27%) (Liu et al. 2016; Allen et al.
2008; Daley et al. 2009; Krakow et al., 2014) (see Table
1). OTC use among people with ID or IS was common
although rates of this use specifically to treat ID or IS
were between 5 and 49% (Liu et al. 2016; Allen et al.
2008; Daley et al. 2009; Krakow et al. 2014). Interest-
ingly, one large Canadian study (n = 953) found that
people with insomnia were twice as likely to use OTCs
for sleep as those with only symptoms of insomnia and
that both those with ID and IS were more likely to use
any OTCs than ‘good’ sleepers. (Daley et al. 2009).
Other studies included in the review provided more
specific descriptions of self-care products than the term
‘OTCs’ and some also included self-care practices used
by adults with ID or IS. Commonly used CAM self-care
for ID or IS includes natural products such as herbal
medicines (including St John’s wort, valerian, lemon
balm, hops, kava kava, chamomile, lemon balm, lavender
and non-described herbal teas), vitamins, minerals and
dietary supplements (including magnesium and mela-
tonin), yoga, self-hypnosis, breathing, warm milk, relax-
ation, meditation, prayer, deep breathing, guided
imagery, PMR, aromatherapy and tai chi. In regards to
conventional self-care, the articles selected for review re-
vealed that common treatments for people with ID or IS
included OTC hypnotics, antihistamines, diphenhydra-
mine products, diet, exercise, and painkillers.
Comparison between some of the individual types of
self-care use reported in the reviewed studies is a chal-
lenge due to the different categories of self-care de-
scribed. However, overall use of self-care by people with
ID and IS was high.
All seven studies included in our review which in-
vestigated the difference in prevalence rates of self-
care between those with and without ID or IS, found
self-care to be higher amongst those with ID or IS
than for those without for all reported kinds of self-
care—both conventional and CAM (Morin et al. 2006;
Bin et al. 2012; Braley et al. 2015; Daley et al. 2009;
Suen et al. 2008; Vallieres et al. 2014; Yeung et al.
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2014)—except physical exercise which was reported to
be marginally higher for those without ID than those
with ID amongst Hong Kong Chinese in one study of
402 participants (Yeung et al. 2014) although another
similar sized study (n = 400) from Hong Kong showed
poor sleepers more frequently set time aside for re-
laxation or relaxing exercise before bed (Suen et al.
2008) indicating that is was more relaxing exercise
that was used as a strategy.
A nationally representative cross-sectional survey of
Australians found herb, vitamin and mineral use to be
twice as high amongst people with ID than those with-
out (20% vs. 10%) (Bin et al. 2012). Similarly Morin et al.
(Morin et al. 2006) identified self-care products and
practices (such as natural products (OR = 3.7), OTC
medications (OR = 2.8) and relaxation (OR = 2.6)) as
more likely to be utilized by people with ID than those
without ID in a large Canadian study.
Four of the articles included in our review on ID or IS
reported prevalence rates of self-care use contemporan-
eously with conventional prescription medications
amongst people with insomnia and symptoms of insomnia
(Henry et al. 2013; Rosenthal et al. 2008; Krakow et al.,
2014; Andrews et al., 2013) including one large US study
of 1210 adults with clinician-diagnosed ID. The study re-
ported that 21% of adults with ID were concurrently using
both OTCs and prescription medications for sleep (Kra-
kow et al., 2014). Amongst the smaller studies included in
our review (n < 500) the prevalence of the combined use
of prescription medications with OTCs ranged from 13 to
73% (mean 44% median 46%) (Henry et al. 2013;
Rosenthal et al. 2008; Andrews et al., 2013).
Prevalence of self-care by adults with other sleep
disturbances (SDB and RLS)
Only three of the 21 studies included in our review report
the use of self-care for sleep disturbances other than ID
and IS (Braley et al. 2015; Petrov et al. 2014; Wahner-
Roedler et al. 2007). All of these studies included patients
with types of SDB (defined in the studies as OSA (Braley
et al. 2015), sleep apnea (Petrov et al. 2014) and OSAHS
(Wahner-Roedler et al. 2007)). A large American study of
21,678 participants with stroke revealed of those using
OTC sleep medications, 11.6% had sleep apnea and 19.1%
were at high risk of sleep apnea. A smaller study from the
U.S.A (n = 406) showed the most common OTC product
used was Diphenhydramine (Benadryl) (Wahner-Roedler
et al. 2007). Another American small sample study also
found diphenhydramine-containing products (common
non-prescription medications) were used by 40% of partic-
ipants with Restless Legs Syndrome (RLS) (Braley et al.
2015). However, the usefulness of this study in regards to
self-care use for RLS is limited due to small sample size
and because all RLS patients had also been diagnosed with
multiple sclerosis (MS). More research with regard to the
use of self-care amongst adults with RLS is required.
Unsurprisingly, with limited available research, there
were no clear patterns reported for contemporaneous
use of self-care and prescription medications for SDB or
RLS. One large US study (n = 21,678) showed that of
those using both prescription and OTC medications,
12% had diagnosed sleep apnea, and 25% had a high risk
of sleep apnea (Petrov et al. 2014). Given the possible
complications with contemporaneous use of prescription
and non-prescription medicines, including herbs, it is
important for health researchers to investigate this use
amongst adults with sleep disturbances such as SDB and
RLS further.
Profile, predictors and motivation for the use of self-care by
adults with ID and IS
The predominant socio-demographic predictors of self-
care products and therapy use for ID or IS, in compari-
son to people who did not engage in self-care for ID or
IS, were being female (Morin et al. 2006; Venn et al.
2013; Sánchez-Ortuño et al. 2009; Homsey and O’Con-
nell 2012; Allen et al. 2008; Krakow et al. 2014) having
attained a higher level of education or income (Morin
et al. 2006; Homsey and O’Connell 2012; Krakow et al.
2014) and being of white ethnicity (Allen et al. 2008;
Krakow et al. 2014). The main predictors that were iden-
tified for the use of self-care products and practices for
ID or IS—being female and having a higher attainment
of education or income—are consistent with wider gen-
eral use of CAM and self-care beyond ID or IS (Bishop
and Lewith 2010; Thomson et al. 2012). However, white
ethnicity as a predictor is less consistently corroborated
by the wider literature with some studies suggesting
black, Asian and Hispanic groups may be more frequent
users of certain self-care options (Cherniack et al., 2008;
Barnes et al. 2004).
Many of the studies included in our review explored
motivations for the use of self-care products and prac-
tices for ID or IS (Morin et al. 2006; Venn et al. 2013;
Cheung et al. 2014; Henry et al. 2013; Matthews et al.
2016; Venn and Arber 2012; Andrews et al., 2013) and
some consistent themes emerged. In particular, a com-
monly reported reason for seeking self-care solutions for
ID or IS was as an alternative to conventional front-line
medical treatment, because of a concern regarding the
safety and long-term efficacy of prescription medications
for sleep (Venn et al. 2013; Cheung et al. 2014; Henry
et al. 2013; Matthews et al. 2016; Venn and Arber 2012;
Andrews et al., 2013). People with ID or IS also had
concerns regarding their GP’s knowledge of effective
treatments or referral pathways that went beyond con-
ventional prescription sleeping medications. The se-
lected studies reported that people with ID or IS often
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believed therefore, their GPs would only be able to help
them with short-term medications that they feared or
believed would have detrimental side effects. In particu-
lar, a fear of addiction to prescribed sleeping pills such
as hypnotics was reported amongst adults with ID or IS
(Venn et al. 2013; Cheung et al. 2014; Henry et al. 2013;
Matthews et al. 2016; Venn and Arber 2012; Andrews
et al., 2013). The literature reported that many people
with ID or IS perceived that prescription medications for
sleep produced unwanted soporific effects the morning
after taking them or that they resulted in unsatisfactory,
non-restorative sleep (Venn et al. 2013; Cheung et al.
2014; Matthews et al. 2016; Venn and Arber 2012; An-
drews et al., 2013). These concerns over conventional
medical responses to IS and ID are supported by general
literature on insomnia (Stinson et al. 2006; Davy et al.
2015; Cheung et al. 2017). These may be valid reasons
for seeking self-care treatments in light of proven side
effects of many frontline prescription medications for in-
somnia (Wang et al. 2014).
The ‘immorality’ (as an indicator of a lack of self-
control because of addiction) of taking prescription or
non-‘natural’ medicines for ID or IS was also reported as
a motivator to try out various ‘natural’ self-help treat-
ments (Venn et al. 2013; Venn and Arber 2012). Inter-
estingly, three papers reported that seeking help for
chronic health conditions other than participants’ IS was
seen as more acceptable; thus, painkillers professionally
prescribed for other conditions—or even a partner’s con-
ditions—were reported to be misappropriated for the
treatment of IS (Venn et al. 2013; Venn and Arber 2012;
Andrews et al., 2013).
For older populations, participants interviewed some-
times believed poor sleep was thought to be commen-
surate with aging, therefore outside the realm of
conventional medical treatment (Henry et al. 2013) and
believed there was an inevitability about their symptoms
which impacted the validity of seeking conventional
treatment or wasting GP’s time. OTC drugs such as
acetaminophen and acetaminophen-diphenhydramine
combination drugs were also taken as an inexpensive
and dependable alternative to prescription medications
for sleep, by adults with insomnia, with fewer side effects
(Henry et al. 2013). However, the above motivating fac-
tors were reported by studies with small samples and
tended to be of low methodological quality and are not
highly generalizable, suggesting the need for nationally
representative research investigating motivations for
self-care use amongst adults with ID and IS.
Another reason identified in the reviewed literature as
motivating self-care products and therapy use among
people with ID or IS, was a desire amongst such users
for a feeling of control and autonomy over their own
health-care (Venn et al. 2013; Henry et al. 2013; Venn
and Arber 2012; Andrews et al., 2013). One U.S. study
on patient responses to insomnia found that 83% of suf-
ferers sought to treat their insomnia using self-care as a
way of ‘wresting control’ of their lives (Henry et al.
2013). This study also reported that self-treatment of in-
somnia by study participants would occur both before
and after treatment by a sleep specialist and that partici-
pants would rather self-treat their insomnia than seek
professional treatment, due to a fear of the stigma at-
tached around having insomnia complaints. 38% of the
sample reported feeling stigmatized directly and others
(figure not reported) mentioned feeling isolated, weak or
abnormal because of their insomnia.
Other studies reviewed reported a perception that
some GPs did not consider ID or IS to be a valid com-
plaint (Venn et al. 2013; Cheung et al. 2014; Venn and
Arber 2012) and, on the other hand, that persons with
ID and IS often did not consider ID or IS as a valid
reason themselves to seek help from a medical profes-
sional (Venn et al. 2013; Cheung et al. 2014; Venn and
Arber 2012).
One large (n = 953) Canadian study found chief rea-
sons for seeking natural (CAM-self-care) medications
were to treat anxiety and stress and to promote relax-
ation (Sánchez-Ortuño et al. 2009) suggesting a desire
by patients for targeting of the causes for ID and IS ra-
ther than insomnia itself, per se and more research re-
garding these beliefs and motivations is needed.
Profile, predictors and motivation for the use of self-care by
adults with other sleep disturbances (SDB and RLS)
One large study (n= > 500) investigating a type of SDB—
sleep apnea—reported that being high risk for the condi-
tion was a predictor of self-care (OTC use) (Petrov et al.
2014) and another article reporting a type SDB—
OSAHS— showed that being female was a predictor
(Wahner-Roedler et al. 2007), specifically for the use of
the OTC, diphenhydramine. It was also reported that
some people with OSAHS engaged in the consumption
of OTC medications due to their perception that their
GP would not allow them prescription medications for
sleep or a fear that their GP would stop their use of
existing prescriptions (Wahner-Roedler et al. 2007).
There was no information on the profile, predictors and
motivations by people with RLS using self-care and more
research is clearly required into this topic for SDB, RLS
and other types of sleep disturbance.
Information-seeking, communication with medical providers
and self-reported effectiveness of self-care by adults with ID
or IS
Amongst the four articles included in the review which
report on participants’ perceptions of effectiveness re-
garding use of self-care products, findings were varied
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although overall, some satisfaction and belief in efficacy
was reported. For example, one study (n = 401) found
self-care products and practices were considered effect-
ive for insomnia by a vast majority of participants who
used them including OTCs (100%), yoga (100%), exercise
(94.7%), Qigong/Tai chi (66.7%), relaxation (66.7%) and
western herbal products (66.7%) (Yeung et al. 2014). An-
other study (n = 300) rated the most successful self-care
strategies by participants with IS to be the use of antihis-
tamines, followed by yoga, PMR, deep breathing, taking
kava kava, melatonin, guided imagery and taking valerian
(Homsey and O’Connell 2012).
Information sources used by people with ID or IS for
self-care treatments included pharmacists (Venn et al.
2013; Cheung et al. 2014; Henry et al. 2013), the media
and the Internet (Venn et al. 2013; Cheung et al. 2014),
television adverts (Henry et al. 2013), books (Henry
et al. 2013), friends, family and work colleagues (Venn
et al. 2013; Cheung et al. 2014; Henry et al. 2013), herb-
alists, CAM practitioners at health food stores or yoga
centers (Cheung et al. 2014; Venn and Arber 2012) and
people’s own experience (Venn et al. 2013; Henry et al.
2013) (no percentages were reported for these findings).
Interestingly, as reported by one small Australian study,
insomnia patients tended not to ask advice of pharma-
cists because they associated them with pharmaco-
logical remedies and only wanted prescription
medicines or alternative medicines”. However, some
participants (no percentages were reported) did indicate
they would like to receive more information from phar-
macists about the efficacy and appropriate application
of CAM medicines to aid sleep (Cheung et al. 2014).
Younger adult participants also looked to university
counselors for information on potential treatments
(Cheung et al. 2014). Men were less likely to report use
of external information sources and were sometimes
unaware of conventional or CAM self-care options for
ID or IS (Venn et al. 2013).
In terms of the communication between medical pro-
viders and adults with ID or IS, the reviewed literature
found that study participants were often not satisfied
with their GPs’ knowledge of self-care or alternative op-
tions to improve sleep (Venn et al. 2013; Cheung et al.
2014; Henry et al. 2013; Matthews et al. 2016; Venn and
Arber 2012; Andrews et al., 2013). People with ID or IS
frequently reported feeling frustrated with medical re-
sponses to their sleep problems and felt they had unmet
healthcare needs (Venn et al. 2013; Bin et al. 2012;
Cheung et al. 2014; Henry et al. 2013; Matthews et al.
2016; Venn and Arber 2012; Andrews et al., 2013). A
large Australian study (n = 8841) found 26% of people
with ID reported an unmet need for health care versus
6.6% of those without ID (Bin et al. 2012). Failing to be
asked about sleep at all or to be listened to and allowed
to contribute to a plan for tackling ID or IS with their
GP was reported (Venn et al. 2013; Cheung et al. 2014;
Matthews et al. 2016; Venn and Arber 2012; Andrews
et al., 2013). People with ID or IS also reported assump-
tions that, or experiences where, GPs would only suggest
short-term medications that they considered harmful
and that GPs would not or did not have knowledge of
viable self-care options to recommend (Venn et al. 2013;
Cheung et al. 2014; Henry et al. 2013; Matthews et al.
2016; Venn and Arber 2012; Andrews et al., 2013). Dis-
closure of the use of self-care products and practices to
medical providers was, in turn, not always provided to
GPs (Venn et al. 2013; Venn and Arber 2012; Andrews
et al., 2013).
The literature also reported that adults with ID or IS
also frequently do not disclose their problems with sleep
at all to medical providers (Venn et al. 2013; Cheung
et al. 2014; Henry et al. 2013; Venn and Arber 2012).
One study reviewed reported that only 21% of people
who had IS disclosed these sleep issues with a medical
provider (Venn and Arber 2012). All of the male partici-
pants in in one small study considered sleep, and the
treatment thereof, to be a matter that should not be dis-
cussed with any health professional at all (Venn et al.
2013). Therefore, opportunity for the discussion of self-
care treatments for the treatment of ID or IS between
medical provider and patient are limited due to this
non-disclosure of the sleep issue in the first instance.
Information-seeking, communication with medical providers
and self-reported effectiveness of self-care by adults with
other sleep disturbances (SDB and RLS)
There were no articles discussing the information-
seeking, communication with medical providers and
self-reported effectiveness of self-care by adults with
SDB, RLS or other sleep disturbances (apart from ID or
IS). In order to understand how patients with sleep dis-
turbances are being informed and what their perceptions
regarding self-care are, further research is crucial.
Appraisal outcomes
Seventeen articles of all 21 articles included in this re-
view were assessed via the quality scoring system. Not-
withstanding a reasonable level of design quality
demonstrated by many articles included in Table 3, to
date, the overall quality of research design is methodo-
logically limited. For example, as assessed by the quality
assessment tool (Table 2) only two articles reported the
use of a representative sampling strategy and seven had
a sample size of > 500. Of seventeen articles, only 3 re-
ported response rates of 75% or higher and ten reported
methodologies that involved a low recall bias.
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Discussion
This paper reports findings from the first comprehen-
sive review of the international literature of self-care
use among populations with sleep disturbances. Not-
withstanding the high number of papers ineligible for
inclusion due to omission of details regarding whether
products and practices were self-care or practitioner-
administered, two thirds of the empirical studies pre-
sented in this paper were published since 2012 - dem-
onstrating a possible growing interest in the use of
various types of self-care for sleep disturbances and a
growing interest in self-care amongst researchers (Mun
et al. 2016).
While the reported use of OTC products for patients
with SDB and RLS was high, only two articles for SDB
and one for RLS fitted our inclusion criteria. Therefore,
further research is required to determine the prevalence
of self-care use among these populations. Further, the
studies of patients with SDB and RLS that were included
in this review only investigated the use of OTC products.
While there is literature available on the efficacy of self-
care practices such as purchasing and using compression
stockings (Lettieri and Eliasson 2009) for RLS and oral
appliances for OSA (Ferguson et al. 2006), there is an
absence of research detailing the prevalence and charac-
teristics of this use. Also, while there is evidence to sup-
port the use of CPAP machines for improved outcomes
in sleep apnea (Marin et al. 2005), patterns of independ-
ent use without prescriptions have not been investigated.
Further research is required to determine what treat-
ments are being independently sought and implemented
by adults with sleep disturbances such as RLS and types
of SDB to aid in the development of effective treatments
and to guide efficacy research in the future.
The identified high prevalence levels of self-care use
for symptoms of ID or IS—necessitates further research.
Research regarding the treatment of ID or IS—clinically
diagnosed or determined using a validated sleep scale/
index—demonstrated that a wide array of treatments are
used. This suggests a lack of consensus amongst people
with such sleep disturbances regarding effective ap-
proaches and/or resolutions to these conditions. These
circumstances are reflected in the wider research evalu-
ating perceived efficacy of treatments for sleeping distur-
bances such as ID by both individuals with sleep
disturbances and those treating them (Everitt et al. 2014;
Sivertsen et al. 2010). Further, evidence indicates a lack
of confidence by adults with sleep disturbances, in the
ability of medical practitioners–or of the prescriptions
they might recommend–to cure or improve sleep distur-
bances over the long term, or to do so without signifi-
cant harm. Whilst there is some evidence frontline
treatments such as benzodiazepines, Dopaminergic
agents, zolpidem and zoplicone may have detrimental
side effects (Wang et al. 2014; Leach and Page 2015;
Gamaldo and Earley 2006), particularly amongst older
people (Wang et al. 2014), OTC medications such as an-
tihistamines and analgesics taken without medical advice
also have potential for serious harm (Goh et al. 2009;
Zhang et al. 2010). This is despite a view by study partic-
ipants with sleep disturbances such as ID or IS reflected
in the reviewed literature that self-care products provide
a safer alternative to conventional prescription treat-
ments. There are also concerns by people with ID or IS
over the side effects of CAM self-care products which in
some cases may have negative effects on people’s ability
to sleep well (Lichstein et al. 2007) and also have limited
evidence for efficacy in the treatment of sleep distur-
bances (Leach and Page 2015). More detailed research to
examine the prevalence of use of specific self-care treat-
ments for persons with various kinds of sleep disturb-
ance is required to identify specific safety issues and
concerns and to better aid health professionals with reli-
able information to guide effective patient care for sleep
disturbances.
Evidence summarized in this review suggests self-
care for the treatment of ID or IS is often not dis-
closed to health professionals which is congruent with
literature on self-care disclosure more generally
(Chung et al. 2011). As studies included in this re-
view have indicated a high level of OTC use for both
ID and IS and some use for other sleep disturbances
such as SDB and RLS, future research exploring how
self-medication of OTC products may contribute to
the risk of harmful drug events is warranted. This is
particularly pertinent in light of the high prevalence
of concomitant use of prescription and non-
prescription medications as identified in our review
for ID or IS and for sleep apnea, which could result
in harmful drug-herb or drug-drug interactions if not
overseen by a qualified health practitioner. The
reviewed literature reveals that while many sufferers
do not themselves disclose their sleep disturbances,
particularly for ID and IS, they do have a desire to be
asked about the existence of sleep disturbances by
medical professionals and then to be listened to in
regards to their treatment preferences. A patient-
centered approach, advocated elsewhere (Meredith
et al. 2017; Meredith et al. 2019), including collabora-
tive methods of treatment and respectful, open com-
munication between the healthcare professional and
patient, may improve the likelihood of patients dis-
closing their use of self-care (Lichstein et al. 2007).
Potential arising from such open communication to
circumvent harmful drug interactions will benefit both
patients and medical practitioners alike. This ap-
proach is particularly pertinent for people with sleep
disturbances, whom, as the wider literature shows
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have an increased likelihood of having comorbid ill-
nesses (Meredith et al. 2017; Smagula et al. 2016).
Whilst there were too few studies reporting on self-
perceived efficacy of self-care products and practices
used for ID or IS (and none for SDB, RLS and other
sleep disturbances) to form reliable generalizations,
there was a significant level of satisfaction amongst
participants for various types of self-care use includ-
ing yoga, OTC medications (such as antihistamines
and acetaminophen), relaxation and deep breathing.
While research has shown deep breathing, relaxation
and yoga exercises can help alleviate overall sleep
quality (Sarris and Byrne 2011; Chien et al. 2015;
Orsal et al. 2014) further research is required regard-
ing the prevalence, safety and efficacy of self-care
treatments such as OTC medications used frequently
for sleep disturbances.; safety concerns for antihista-
mines in particular have been highlighted (Goh et al.
2009; Zhang et al. 2010). Additionally, in light of sug-
gestions made by research participants that they
would like treatment preferences for sleep distur-
bances such as ID or IS to be discussed collabora-
tively with their GP, it may be helpful for medical
practitioners to ask about the use of—or interest in—
non-prescription alternatives for ID or IS and other
sleep disturbances. Although this review suggests that
patients with ID or IS do not generally consider their
GP as possessing knowledge of self-care options for
sleep disturbances, evidence also suggests that pa-
tients frequently do not ask about a GP’s knowledge
and/or advice about self-care options for the treat-
ment of sleep disturbances (Morin et al. 2006; Stinson
et al. 2006). This is also indicated in the wider gen-
eral literature regarding self-care options- particularly
CAM self-care (Thomson et al. 2012; Frawley et al.
2014; Sohl et al. 2015).
Although CAM self-care and conventional self-care
for the treatment or improvement of sleep disturbances
is being increasingly investigated in the literature and
reported prevalence of use of self-care for sleep distur-
bances is significant, limitations remain in the ability to
synthesize results and make reliable generalizations
about what self-care is being used and why. First, defi-
nitions of self-care are divergent in the literature (Mun
et al. 2016). While some papers report and focus on
just one aspect of self-care, such as herbal medicines or
antihistamines, others blend results with non-self-care
types (e.g. conventional medicines including both pre-
scription and non-prescription). Second, comparing
studies examining sleep disturbances has been historic-
ally challenging due to varying classifications employed
(Morin and Espie 2011). For example, definitions of
one type of sleep disturbance reviewed in this paper, in-
somnia, vary immensely in the literature with some
studies reporting just one or more of the symptoms of
insomnia: difficulty maintaining sleep, difficulty initiat-
ing sleep waking up too early, and sometimes, poor
quality or non-restorative sleep (Roth 2007) while other
studies include diagnostic criteria that includes for ex-
ample, subjective harm to health or suffering as a con-
sequence of the condition. Others still have applied
stricter definitions, for example, The Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition
(DSM-5) (Association AP 2013). It has been suggested
such discrepancies in the definition of insomnia alone
largely account for incongruent estimations of adult in-
somnia prevalence rates of between 6 to 30% inter-
nationally (Roth 2007).
However, the limitations of these problems have been
minimized within this review by including only literature
employing a validated sleep index measure or scoring
system based on established diagnostic criteria in their
methodology, or including participants who had received
a clinical diagnosis of a sleep disorder (see Table 1 for
sleep assessment tools used in individual studies). While
the sleep disturbances and problems being examined dif-
fered between many of the studies included in this re-
view, the instruments used to measure the sleep
disturbances (which included ID, IS, clinically-measured
poor sleep, SWD, OSA and RLS) are visible in the re-
sults, allowing for deeper analysis. Likewise, although the
parameters of self-care are divergent in the reviewed lit-
erature, only papers demonstrating self-care products
and practices as distinct from either practitioner-based
conventional or CAM medicine, were included in the re-
view. Third, this review is limited to English language
publications therefore the omission of non-English ma-
terials is likely to introduce a level of bias. Fourth, many
of the studies included in the review used small sample
sizes and/or were unrepresentative of the general popu-
lation making it difficult to draw reliable conclusions on
many aspects of self-care use. Fifth, this review investi-
gates self-care use across countries with widely varied
accessibility to both mainstream health-care and self-
care options.
Despite these limitations, the empirical findings col-
lated in this review do nonetheless suggest a significant
use of self-care among people with sleep disturbances.
Equally significant is the evidence of the contemporan-
eous use of self-care products with conventional pre-
scription medications, a finding which is consistent with
international literature on self-care use in the broader
population (Bishop and Lewith 2010; Chung et al. 2011).
Conclusions
A significant percentage of people with sleep distur-
bances such as ID or IS, SDB and RLS appear to utilize
self-care practices and products and such use frequently
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appears contemporaneous with conventional prescrip-
tion medications although research regarding this use is
limited for sleep disturbances other than ID or IS. When
dealing with patients presenting symptoms of sleep dis-
turbances, medical practitioners such as GPs, need to ac-
tively inquire into patients’ use of self-care products and
practices and into their treatment preferences. This dia-
logue will enable medical practitioners to advise their
patients about the safety and efficacy of self-care prod-
ucts and practices and may also help to avoid harmful
drug-drug or drug-herb interactions that may currently
be occurring due to a lack of disclosure of concomitant
use of self-care and prescription medications by patients
to their GPs. Further, GPs should inquire about the ex-
istence of symptoms of sleep disturbances amongst pa-
tients they may be treating for comorbid conditions as
patients frequently do not disclose issues with sleep.
Medical professionals may also consider alternative
treatment suggestions, in consultation with their patients
and according to patient preferences, beyond short-term
conventional medical interventions such as hypnotics. In
light of both the significant use of, and perceived effect-
iveness of, many self-care options such as OTCs, herbal
products, relaxation, yoga and exercise, health re-
searchers should further investigate both efficacy and
safety for self-care options which policy makers could
help to distribute this information to both the public
and medical professionals.
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